TrialThe New England journal of medicine1999

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

H B Rubins et al.PubMed ↗Publisher ↗

No numbers read from the abstract.